Skip links

EKTERLY® (sebetralstat)

Full Name EKTERLY® (sebetralstat)
Drug sebetralstat
Manufacturer KalVista Pharmaceuticals
Route of Administration Oral
Site of Care Home
Approved Indication The treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older
Disease Hereditary Angioedema (HAE)
Therapeutic Area Allergy & Immunology
Enrollment Form Link Enrollment Form – English language
Enrollment Form – Spanish language
Phone Number 800-356-4252
Fax Number 847-631-6918
Product Website ekterly.com/